EPIRUS Biopharmaceuticals, Inc. Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31)
EPIRUS Biopharmaceuticals, Inc. reported Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) of 61.68% for the 3-month period ending 2014-09-30, per its 10-K filed 2016-03-29.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsExpectedVolatilityRate · last filed 2016-03-29
- EPIRUS Biopharmaceuticals, Inc. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2014-09-30 was 61.68%.
| Period end | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 3 month |
|---|---|
| 2014-09-30 | 61.68% 10-K · filed 2016-03-29 |